Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Omics Approaches and Technologies in COVID-19 ; : 301-320, 2022.
Article in English | Scopus | ID: covidwho-2305195

ABSTRACT

Coronavirus disease 2019 (COVID-19), the disease cause by the novel severe acute respiratory syndrome coronavirus 2 represents a global, unresolved challenge for researchers and clinicians alike. In the shadow of overwhelmed healthcare systems, the pressure to produce knowledge, standard operating procedures, efficacious treatments, and prophylactic agents has been unlike any other occasion in recent history. Systems biology, an assortment of methods that aim to model biological systems and their properties has risen to meet this multifaceted challenge. In this chapter, we review approaches and breakthroughs of systems biology research in COVID-19, along with the nascent clade of phenomics, a deep-phenotyping systems concept that has enabled the real-time integration of big data and analytical methods in clinical decision making. © 2023 Elsevier Inc. All rights reserved.

2.
Brain Disorders ; 3 (no pagination), 2021.
Article in English | EMBASE | ID: covidwho-2285335

ABSTRACT

Introduction: (IFITM3) is an innate immune protein that has been identified as a novel gamma-secretase (gammas) modulator. FYN is a kinase that stabilizes IFITM3 on the membrane, primes APP for amyloidogenic gammas processing and mediates tau oligomerization. The purpose of this study is to explore the role of FYN and IFITM3 in AD and COVID-19, expanding on previous research from our group. Method(s): A 520 gene signature containing FYN and IFITM3 (termed Ia) was extracted from a previously published meta-analysis of Alzheimer's disease (AD) bulk- and single nuclei sequencing data. Exploratory analyses involved meta-analysis of bulk and single cell RNA data for IFITM3 and FYN differential expression per CNS site and cellular type. Confirmatory analyses, gene set enrichment analysis (GSEA) on Ia was performed to detect overlapping enriched biological networks between COVID-19 with AD. Result(s): Bulk RNA data analysis revealed that IFITM3 and FYN were overexpressed in two CNS regions in AD vs. Controls: the temporal cortex Wilcoxon p-value=1.3e-6) and the parahippocampal cortex Wilcoxon p-value=0.012). Correspondingly, single cell RNA analysis of IFITM3 and FYN revealed that it was differentially expressed in neurons, glial and endothelial cells donated b AD patients, when compared to controls. Discussion(s): IFITM3 and FYN were found as interactors within biological networks overlapping between AD and SARS-CoV-2 infection. Within the context of SARS-CoV-2 induced tau aggregation and interactions between tau and Ab1-42, the FYN - IFITM3 regulome may outline an important innate immunity element responsive to viral infection and IFN-I signaling in both AD and COVID-19.Copyright © 2021 The Authors

SELECTION OF CITATIONS
SEARCH DETAIL